CD274 and myeloproliferative disorder: In the treatment of MPN, it could be beneficial to combine CALR vaccines with immunomodulatory treatments53 such as interferon-alpha (IFN-α)54 or programmed death 1 ligand (PD-L1)55 as a combinatorial cancer vaccination53.